跳至主要内容
临床试验/CTRI/2018/01/011551
CTRI/2018/01/011551已完成4 期

A study of Escitalopram Add-on in patients with stable schizophrenia having subsyndromal depressive symptoms

Pooja Singh0 个研究点目标入组 66 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients aged between 18 to 50 years.
  • 2)Availability of a reliable informant.
  • 3)Written informed consent from the patient and/or informant.
  • 4)Diagnosis of Schizophrenia as per ICD-10, DCR.
  • 5)Satisfying operational definition of stable schizophrenia.
  • 6)Having SSDs as defined for the purpose of this study

排除标准

  • 1)Patients having clinically significant medical disorder / disability or taking treatment for same.
  • 2)Any comorbid psychiatric disorder other than nicotine dependence.
  • 3)Patients already receiving antidepressants or mood stabilisers during last 8 weeks.
  • 4)Patients who have received electroconvulsive therapy, other somatic treatments or any form of Psychotherapy during the last six months.
  • 5)Any significant abnormality in routine investigations at baseline (Hb, TLC, DLC, RBS, S.Urea, S.Creatinine, LFT)
  • 6)Pregnant and lactating females.

研究者

发起方
Pooja Singh

相似试验